Glutamine metabolism genes prognostic signature for stomach adenocarcinoma and immune infiltration: potential biomarkers for predicting overall survival

Glutamine metabolism genes prognostic signature for stomach adenocarcinoma and immune infiltration: potential biomarkers for predicting overall survival

BackgroundStomach adenocarcinoma (STAD), caused by mutations in stomach cells, is characterized by poor overall survival. Chemotherapy is commonly administered for stomach cancer patients following surgical resection. An imbalance in tumor metabolic pathways is connected to tumor genesis and growth....

Full description

Bibliographic Details
Main Authors:	Hui Li, Zixuan Wu, Yu Zhang, Xiaohui Lu, Lili Miao
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2023-06-01
Series:	Frontiers in Oncology
Subjects:	STAD GlnMgs immunity m6A and immune checkpoint drug prediction CNV
Online Access:	https://www.frontiersin.org/articles/10.3389/fonc.2023.1201297/full

Similar Items

Bioinformatics and machine learning were used to validate glutamine metabolism-related genes and immunotherapy in osteoporosis patients
by: Lei Wang, et al.
Published: (2023-09-01)

Glutamine metabolism-related genes and immunotherapy in nonspecific orbital inflammation were validated using bioinformatics and machine learning
by: Zixuan Wu, et al.
Published: (2024-01-01)

Constructing and validating of m6a-related genes prognostic signature for stomach adenocarcinoma and immune infiltration: Potential biomarkers for predicting the overall survival
by: Jing Yang, et al.
Published: (2022-12-01)

Pyrimidine metabolism regulator-mediated molecular subtypes display tumor microenvironmental hallmarks and assist precision treatment in bladder cancer
by: Zixuan Wu, et al.
Published: (2023-08-01)

Comprehensive Characterization of Transforming Growth Factor Beta Receptor 1 in Stomach Adenocarcinoma Identifies a Prognostic Signature for Predicting Clinical Outcomes and Immune Infiltrates
by: He Y, et al.
Published: (2022-03-01)

Identification of clinical prognostic factors and analysis of ferroptosis-related gene signatures in the bladder cancer immune microenvironment
by: Jiafu Ma, et al.
Published: (2024-01-01)

An Immune-Related Prognostic Signature Predicts Overall Survival in Stomach Adenocarcinomas
by: Kangjie Zhou, et al.
Published: (2022-05-01)

Development and validation of prognostic index based on purine metabolism genes in patients with bladder cancer
by: Zixuan Wu, et al.
Published: (2023-09-01)

A novel diabetic foot ulcer diagnostic model: identification and analysis of genes related to glutamine metabolism and immune infiltration
by: Hongshuo Shi, et al.
Published: (2024-01-01)

Neuropilin1 Expression Acts as a Prognostic Marker in Stomach Adenocarcinoma by Predicting the Infiltration of Treg Cells and M2 Macrophages
by: Ji Young Kang, et al.
Published: (2020-05-01)

Ferroptosis-related gene SLC1A5 is a novel prognostic biomarker and correlates with immune infiltrates in stomach adenocarcinoma
by: Dandan Zhu, et al.
Published: (2022-03-01)

Identification of RFX5 as prognostic biomarker and associated with immune infiltration in stomach adenocarcinoma
by: Lili Guo, et al.
Published: (2022-08-01)

LRMP Associates With Immune Infiltrates and Acts as a Prognostic Biomarker in Lung Adenocarcinoma
by: Xin Jin, et al.
Published: (2021-11-01)

A Signature Based on Costimulatory Molecules for the Assessment of Prognosis and Immune Characteristics in Patients With Stomach Adenocarcinoma
by: Bangjie Chen, et al.
Published: (2022-07-01)

SNCA correlates with immune infiltration and serves as a prognostic biomarker in lung adenocarcinoma
by: Xiuao Zhang, et al.
Published: (2022-04-01)

Identification of miRNA biomarkers for stomach adenocarcinoma
by: Hao Qian, et al.
Published: (2022-05-01)

Glutamine metabolism and radiosensitivity: Beyond the Warburg effect
by: Ryan S. Alden, et al.
Published: (2022-11-01)

Chronic unpredictable mild stress induced depression-like behaviours and glutamate-glutamine cycling dysfunctions in both blood and brain of mice
by: Ya-Ping Chen, et al.
Published: (2019-01-01)

Signatures of Multi-Omics Reveal Distinct Tumor Immune Microenvironment Contributing to Immunotherapy in Lung Adenocarcinoma
by: Ziqi Huang, et al.
Published: (2021-09-01)

Glutamine metabolism in cancers: Targeting the oxidative homeostasis
by: Tengfang Gong, et al.
Published: (2022-10-01)

A pyroptosis‐related signature predicts prognosis and indicates immune microenvironment infiltration in glioma
by: Jia Chen, et al.
Published: (2023-02-01)

IRF7 is a Prognostic Biomarker and Associated with Immune Infiltration in Stomach Adenocarcinoma
by: Guo L, et al.
Published: (2021-12-01)

Comprehensive Molecular Analyses of an SLC Family-Based Model in Stomach Adenocarcinoma
by: Tao Yu, et al.
Published: (2022-10-01)

Effect of Supplementing Different Levels of L-Glutamine on Holstein Calves during Weaning
by: Shuo Wang, et al.
Published: (2022-03-01)

The plant defensin gene AtPDF2.1 mediates ammonium metabolism by regulating glutamine synthetase activity in Arabidopsis thaliana
by: Junyue Yao, et al.
Published: (2019-12-01)

Cancer-Specific Immune Prognostic Signature in Solid Tumors and Its Relation to Immune Checkpoint Therapies
by: Shaoli Das, et al.
Published: (2020-09-01)

New progress of glutamine metabolism in the occurrence, development, and treatment of ovarian cancer from mechanism to clinic
by: Xiaojing Yang, et al.
Published: (2022-11-01)

Classification of stomach adenocarcinoma based on fatty acid metabolism-related genes frofiling
by: Chunhua Liu, et al.
Published: (2022-08-01)

Analysis of genomic and transcriptomic variations as prognostic signature for lung adenocarcinoma
by: Talip Zengin, et al.
Published: (2020-09-01)

A combined aging and immune prognostic signature predict prognosis and responsiveness to immunotherapy in melanoma
by: Wenchang Lv, et al.
Published: (2022-08-01)

The Immune Checkpoint Landscape in Tumor Cells of Pancreatic Ductal Adenocarcinoma
by: Florian N. Loch, et al.
Published: (2023-01-01)

An integrated analysis of prognostic mRNA signature in early- and progressive-stage gastric adenocarcinoma
by: Xiaoling Hong, et al.
Published: (2023-01-01)

Identification of a Pyroptosis-Related Gene Signature for Predicting Overall Survival and Response to Immunotherapy in Hepatocellular Carcinoma
by: Susu Zheng, et al.
Published: (2021-12-01)

Pyroptosis-Related LncRNA Signatures Correlate With Lung Adenocarcinoma Prognosis
by: Hua Huang, et al.
Published: (2022-03-01)

High OX-40 expression in the tumor immune infiltrate is a favorable prognostic factor of overall survival in non-small cell lung cancer
by: Erminia Massarelli, et al.
Published: (2019-12-01)

GDF10 and IDO1 as a thyroid cancer prognostic biomarker associated with immune infiltration
by: Zhao-bao Lv, et al.
Published: (2024-03-01)

Different responses of the GlnB and GlnZ proteins upon in vitro uridylylation by the Azospirillum brasilense GlnD protein
by: L.M. Araújo, et al.
Published: (2008-04-01)

Identification and verification of a prognostic autophagy-related gene signature in hepatocellular carcinoma
by: Zhen Ma, et al.
Published: (2024-02-01)

Construction of stomach adenocarcinoma prognostic signature based on anoikis-related lncRNAs and clinical significance
by: Lina Lu, et al.
Published: (2023-12-01)

A novel pyroptosis-related prognostic signature for lung adenocarcinoma: Identification and multi-angle verification
by: Xinyue Wang, et al.
Published: (2023-04-01)